Citations
3 publicationsPublications from researchers using this productDescription
Vincristine is an inhibitor of polymerization of microtubules by binding to tubulin with IC50 of 32μM in a cell-free assay. Vincristine can induces apoptosis[1].
Vincristine (100nM; 48h) induces distinct death programs in primary ALL cells depending on cell cycle phase, and cells in G1 are susceptible to perturbation of interphase microtubules[2].Vincristine (5nM; 4, 8, 24h) triggers a cascade of axon pathology, causing mitochondrial dysfunction that leads to elevated axonal ROS levels and SARM1-dependent axon degeneration[3].Vincristine (0.3-10nM; 48h) and SAHA on T cell leukemic cells resulted in a change in microtubule dynamics contributing to M phase arrest followed by induction of the apoptotic pathway[4].
Vincristine (Pre: <10μg or 0.5mg/kg; Post: 10μg; ip; 25d) causes swelling and redness of the injected paw as well as a strong dose-dependent infiltration of immune cells to the site of injection. Consistent with the neuro-inflammatory signature, mechanical allodynia was decreased in mice lacking Tlr4, as well as in mice treated with minocycline[5].Vincristine (3mg/kg; iv; 1 time) administrated by a single i.p. injection to mice bearing bilateral subcutaneous xenografts Rh12 or Rh18, induces mean growth delay of >120 and >52day, and repopulating fractions of 0.06% and 5%, respectively[6].
References:
[1].Jordan MA, Himes RH, Wilson L. Comparison of the effects of vinblastine, Vincristine, vindesine, and vinepidine on microtubule dynamics and cell proliferation in vitro. Cancer Res. 1985 Jun;45(6):2741-7.
[2].Kothari A, Hittelman W N, Chambers T C. Cell cycle–dependent mechanisms underlie Vincristine-induced death of primary acute lymphoblastic leukemia cells[J]. Cancer research, 2016, 76(12): 3553-3561.
[3].Gomez-Deza J, Slavutsky A L, Nebiyou M, et al. Local production of reactive oxygen species drives Vincristine-induced axon degeneration[J]. Cell Death & Disease, 2023, 14(12): 807.
[4].Chao MW, Lai MJ, Liou JP, Chang YL, Wang JC, Pan SL, Teng CM. The synergic effect of Vincristine and vorinostat in leukemia in vitro and in vivo. J Hematol Oncol. 2015 Jul 10;8:82.
[5].Starobova H, Mueller A, Allavena R, et al. Minocycline prevents the development of mechanical allodynia in mouse models of Vincristine-induced peripheral neuropathy[J]. Frontiers in Neuroscience, 2019, 13: 653.
[6].Baguley BC, Holdaway KM, Thomsen LL, Zhuang L, Zwi LJ. Inhibition of growth of colon 38 adenocarcinoma by vinblastine and colchicine: evidence for a vascular mechanism. Eur J Cancer. 1991;27(4):482-7.
Protocol
| Cell experiment [1]: | |
Cell lines | ALL-2 cells |
Preparation Method | The ALL-2 cells in either G1 or G2/M phases were treated with vehicle (0.1% DMSO) or 100nM Vincristine, harvested at specific times, and DNA content analyzed. |
Reaction Conditions | 100nM; 48h |
Applications | When treated with Vincristine, cells underwent M phase arrest, with 86.4% cells having 4N DNA content within 8h of Vincristine treatment, and by 48h, 50% of cells had <2N DNA content. |
| Animal experiment [2]: | |
Animal models | Vincristine-induced peripheral neuropathy (VIPN) Model |
Preparation Method | Vincristine (<10μg; ip; or 0.5mg/kg; ip) or vehicle (PBS; ip) were administered for five consecutive days, with 2 days break, followed by another five consecutive injections. The highest Vincristine dose (10μg; ip) was administered for four consecutive days, followed by 5 days break and another two injections. Minocycline (25mg/kg; ip) was administered once daily, 3 days before Vincristine administration, and then with each Vincristine injection. |
Dosage form | 1-12 days: <10μg or 0.5mg/kg; 12-25 days: 10μg; ip; 25 days |
Applications | Injection of Vincristine causes swelling and redness of the injected paw as well as a strong dose-dependent infiltration of immune cells to the site of injection. Consistent with the neuro-inflammatory signature, mechanical allodynia was decreased in mice lacking Tlr4, as well as in mice treated with minocycline. |
References: | |
Product Documents
Chemical Properties
Use stock solutions within 6 months when stored at -80°C or within 1 month when stored at -20°C.
To improve solubility, warm the tube to 37°C and sonicate it for an appropriate period.
CalculatorsMolarity / Dilution / Molecular Weight / Unit Conversion / In Vivo Formulation / Solubility
Reviews
Review for Vincristine
- 5 Star100%
- 4 Star0%
- 3 Star0%
- 2 Star0%
- 1 Star0%
